Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Single-arm Clinical Investigation for the Evaluation of Safety and Effectiveness of Microport CardioFlow Transcatheter Mitral Valve Replacement System in the Treatment of Moderate to Severe or Severe Symptomatic Mitral Regurgitation(CF-TMVR)

NCT07857343 is registered in ClinicalTrials.gov with Shanghai MicroPort CardioFlow Medtech Co., Ltd. as lead sponsor.

NCT NCT07857343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07857343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Single-arm Clinical Investigation for the Evaluation of Safety and Effectiveness of Microport CardioFlow Transcatheter Mitral Valve Replacement System in the Treatment of Moderate to Severe or Severe Symptomatic Mitral Regurgitation(CF-TMVR)
Lead sponsor
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
January 1, 2035
Enrollment
152 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative mitral regurgitation